TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07080931: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study on the Efficacy and Safety of 5% Minoxidil Foam in the Treatment of Female Androgenetic Alopecia

Sponsor: Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd. · Phase: PHASE3 · Area: DERMATOLOGY_AESTHETIC · Target Enrollment: 294 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$11,723,520

Rescue Site Savings

+$7,730,196

Unlock Full NCT07080931 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07080931 Rescue Dossier →